 |
|
|
| |
HAART Treatment Interruption Following Adoptive Transfer of Zinc Finger Nuclease (ZFN) CCR5 Modified AutologousCD4 T-cells (SB-728-T) to HIV-infected Subjects Demonstrates Durable Engraftment and Suppression of Viral Load
|
| |
| |
Reported by Jules Levin
ICAAC 2011 Sept Chicago
Dale Ando1, Pablo Tebas2, David Stein3, Shelley Wang1, Gary Lee1, Michael Holmes1, Philip Gregory1, Marty Giedlin1, Winson Tang1, and Carl June2
1Sangamo BioSciencesInc, Richmond, CA; 2U PENN, Philadelphia, PA; and 3Albert Einstein College of Medicine, Bronx, NY
|
| |
|
|
|
|
|
